Home / Health / US Sends Experimental Ebola Drug to Africa
US Sends Experimental Ebola Drug to Africa
26 Jun
Summary
- Experimental Ebola treatment and diagnostic tests are being sent to Africa.
- MBP134, an experimental monoclonal antibody therapy, is being used.
- The Bundibugyo strain of Ebola has no approved vaccines or treatments.
The United States is actively supporting efforts to contain an ongoing Bundibugyo ebolavirus outbreak in Africa. Health officials announced that experimental Ebola treatments are being dispatched to the affected regions, alongside 2,500 diagnostic tests. This initiative is spearheaded by the Administration for Strategic Preparedness and Response (ASPR).
The focus is on aiding response efforts in the Democratic Republic of the Congo and Uganda. Notably, the Bundibugyo strain of Ebola currently has no approved vaccines or treatments, highlighting the critical need for experimental countermeasures. As part of this response, doses of MBP134, an experimental monoclonal antibody therapy, are being transferred for compassionate use.
